{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:56:14Z","timestamp":1774036574439,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Japanese Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["Cancer Control-General-23EA1033"],"award-info":[{"award-number":["Cancer Control-General-23EA1033"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast, cervical and ovarian cancers significantly affect young and middle-aged women, both physically and socially. However, relevant comprehensive stratified analyses are limited. Using Japanese data from CONCORD-3, a global cancer survival surveillance program, we analyzed long-term survival trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 16 Japanese population-based cancer registries were analyzed for women diagnosed aged 15\u201399\u00a0years during 2000\u20132014 with a tumor originating in the breast, cervix uteri or ovaries. Follow-up was extended to five years post-diagnosis or until December 31st, 2014. In situ tumors and death-certificate-only registrations were excluded. Five-year net survival was estimated with the Pohar Perme estimator by calendar period of diagnosis, morphology and stage, and age-standardized with International Cancer Survival Standard weights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During 2000\u20132014, 5-year net survival improved for breast cancer from 85.9% (95% CI, 85.2\u201386.6%) to 89.4% (88.9\u201389.9%), for cervical cancer from 67.5% (66.3\u201368.7%) to 71.4% (70.4\u201372.3%), and for ovarian cancer from 35.5% (33.8\u201337.2%) to 46.3% (44.9\u201347.7%). Five-year survival for tumors diagnosed at a localized stage remained consistently high (&amp;gt;98% for breast cancer and\u00a0&amp;gt;\u00a090% for cervical cancer). Ovarian cancer survival varied greatly according to morphology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Five-year net survival for women with cancers of the breast, cervix, and ovary) in Japan improved during 2000\u20132014, and remained at a globally high level throughout this period. These gains are probably attributable to earlier detection of breast and cervical cancers and advances in multimodal treatment for all cancers. Survival for distant-stage cervical and ovarian cancers remains a challenge, underscoring the need for enhanced screening and treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jjco\/hyaf114","type":"journal-article","created":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T07:31:19Z","timestamp":1751182279000},"page":"i73-i86","source":"Crossref","is-referenced-by-count":1,"title":["Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000\u201314 (CONCORD-3)"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-5283","authenticated-orcid":false,"given":"Kaname","family":"Watanabe","sequence":"first","affiliation":[{"name":"Cancer Prevention and Control Division, Kanagawa Cancer Center Research Institute , 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515 ,","place":["Japan"]},{"name":"Department of Genetic Medicine, Kanagawa Cancer Center , 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7244-9526","authenticated-orcid":false,"given":"Veronica","family":"Di Carlo","sequence":"additional","affiliation":[{"name":"Cancer Survival Group, London School of Hygiene and Tropical Medicine , Keppel Street, London WC1E 7HT,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-0865","authenticated-orcid":false,"given":"Hiromi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Radiation Effects Research Foundation , 5-2 Hijiyama Park, Minami-ku, Hiroshima 732-0815,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-9477","authenticated-orcid":false,"given":"Sho","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control Division, Kanagawa Cancer Center Research Institute , 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515 ,","place":["Japan"]},{"name":"Graduate School of Health Innovation, Kanagawa University of Human Services , 3-25-10 Tonomachi, Kawasaki-ku, Kawasaki 210-0821,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7741-6465","authenticated-orcid":false,"given":"Choy-Lye","family":"Chei","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control Division, Kanagawa Cancer Center Research Institute , 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515 ,","place":["Japan"]},{"name":"Department of Genetic Medicine, Kanagawa Cancer Center , 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-4911","authenticated-orcid":false,"given":"Hiroto","family":"Narimatsu","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control Division, Kanagawa Cancer Center Research Institute , 2-3-2 Nakao, Asahi-ku, Yokohama 241-8515 ,","place":["Japan"]},{"name":"Department of Genetic Medicine, Kanagawa Cancer Center , 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515,","place":["Japan"]},{"name":"Graduate School of Health Innovation, Kanagawa University of Human Services , 3-25-10 Tonomachi, Kawasaki-ku, Kawasaki 210-0821,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-1108","authenticated-orcid":false,"given":"Melissa","family":"Matz","sequence":"additional","affiliation":[{"name":"Cancer Survival Group, London School of Hygiene and Tropical Medicine , Keppel Street, London WC1E 7HT,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5200-9310","authenticated-orcid":false,"given":"Izumi","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Saitama Prefectural University , 820, Sannomiya, Koshigaya-shi, Saitama 343-8540,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8655-5837","authenticated-orcid":false,"given":"Akiko","family":"Shibata","sequence":"additional","affiliation":[{"name":"Yamagata Prefectural Central Hospital , 1800 Oaza-Aoyanagi, Yamagata City, Yamagata 990-2214,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9782-8637","authenticated-orcid":false,"given":"Kayo","family":"Nakata","sequence":"additional","affiliation":[{"name":"Cancer Control Center, Osaka International Cancer Institute , 3-1-69 Otemae, Chuo-ku, Osaka City, Osaka 541-8567,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-5039","authenticated-orcid":false,"given":"Mari","family":"Kajiwara Saito","sequence":"additional","affiliation":[{"name":"Cancer Control Center, Osaka International Cancer Institute , 3-1-69 Otemae, Chuo-ku, Osaka City, Osaka 541-8567,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-3037","authenticated-orcid":false,"given":"Masashi","family":"Matsuzaka","sequence":"additional","affiliation":[{"name":"Hirosaki University Hospital , 53, Honcho, Hirosaki, Aomori 036-8563 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0712-2505","authenticated-orcid":false,"given":"Marisa","family":"Nishio","sequence":"additional","affiliation":[{"name":"Division of Prevention, Institute for Cancer Control, National Cancer Center , 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045,","place":["Japan"]},{"name":"Department of Medical Statistics , Faculty of Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0762-1147","authenticated-orcid":false,"given":"Isao","family":"Oze","sequence":"additional","affiliation":[{"name":"Division of Cancer Information and Control, Aichi Cancer Center Research Institute , 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4626-0644","authenticated-orcid":false,"given":"Rina","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Hirosaki University Graduate School of Medicine \u00a0 5, Zaifucho, Hirosaki Aomori 036-8562 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0331-3235","authenticated-orcid":false,"given":"Laureline","family":"Gatellier","sequence":"additional","affiliation":[{"name":"Division of International Health Policy Research, Institute for Cancer Control, National Cancer Center , 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5234-0507","authenticated-orcid":false,"given":"Isao","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology, NHO Shikoku Cancer Center , 160 Ko, Minamiumenomoto-machi, Matsuyama, Ehime 791-0280,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8023-4581","authenticated-orcid":false,"given":"Hidemi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Cancer Information and Control, Aichi Cancer Center Research Institute , 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7922-1871","authenticated-orcid":false,"given":"Norihiro","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Epidemiology, Center for Cancer Research, Shikoku Cancer Center , 160 Ko, Minamiumenomoto-machi, Matsuyama, Ehime 791-0280 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Epidemiology, Center for Cancer Research, Shikoku Cancer Center , 160 Ko, Minamiumenomoto-machi, Matsuyama, Ehime 791-0280 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Kaizaki","sequence":"additional","affiliation":[{"name":"Fukui Prefectural Hospital , 2-8-1, Yotsui, Fukui-city, Fukui 910-8526 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Moki","sequence":"additional","affiliation":[{"name":"Gunma Health Foundation , 16-1 Horinoshita-machi, Maebashi 371-0005 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuki","family":"Kurosawa","sequence":"additional","affiliation":[{"name":"Ibaraki Prefectural Office , 978-6, Kasahara-cho, Mito, Ibaraki 310-8555,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nemoto","sequence":"additional","affiliation":[{"name":"Ibaraki Pharmaceutical Association Inspection Center , 978-47, Kasahara-cho, Mito, Ibaraki 310-0852,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0454-0322","authenticated-orcid":false,"given":"Seiki","family":"Kanemura","sequence":"additional","affiliation":[{"name":"Miyagi Cancer Center Research Institute , 47-1 Nodayama, Medeshima-Shiote, Natori, Miyagi 981-1293,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Miyashiro","sequence":"additional","affiliation":[{"name":"Cancer Control Center, Osaka International Cancer Institute , 3-1-69 Otemae, Chuo-ku, Osaka City, Osaka 541-8567,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Mori","sequence":"additional","affiliation":[{"name":"Saga-ken Medical Centre Koseikan , 400 Nakabaru, Kasemachi, Saga 840-8571,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Fujita","sequence":"additional","affiliation":[{"name":"Tochigi Cancer Center , 4-9-13, Yohnan, Utsunomiya, Tochigi 320-0834,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7311-1233","authenticated-orcid":false,"given":"Tomohiro","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Division of International Health Policy Research, Institute for Cancer Control, National Cancer Center , 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8940-3807","authenticated-orcid":false,"given":"Michel P","family":"Coleman","sequence":"additional","affiliation":[{"name":"Cancer Survival Group, London School of Hygiene and Tropical Medicine , Keppel Street, London WC1E 7HT,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-3766","authenticated-orcid":false,"given":"Claudia","family":"Allemani","sequence":"additional","affiliation":[{"name":"Cancer Survival Group, London School of Hygiene and Tropical Medicine , Keppel Street, London WC1E 7HT,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2026032004353029700_ref1","volume-title":"Number of incident cases and cancer incidence in","author":"National Cancer Registry","year":"2020"},{"key":"2026032004353029700_ref2","article-title":"Monitoring of cancer incidence in Japan - Survival 2009\u20132011 (in Japanese).","year":"2020"},{"key":"2026032004353029700_ref3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/jjco\/hyx070","article-title":"Childhood, adolescent and young adult cancer incidence in Japan in 2009-2011","volume":"47","author":"Katanoda","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"2026032004353029700_ref4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/tbj.12023","article-title":"The evolution of breast self-examination to breast awareness","volume":"18","author":"Mac Bride","year":"2012","journal-title":"Breast J"},{"key":"2026032004353029700_ref5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.6004\/jnccn.2023.0046","article-title":"NCCN guidelines\u00ae insights: breast cancer screening and diagnosis, version 1.2023","volume":"21","author":"Bevers","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"2026032004353029700_ref6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jpeds.2018.09.013","article-title":"Cancer prevention education for providers, staff, parents, and teens improves adolescent human papillomavirus immunization rates","volume":"205","author":"Suryadevara","year":"2019","journal-title":"J Pediatr"},{"key":"2026032004353029700_ref7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"2026032004353029700_ref8","volume-title":"International classification of diseases for oncology","author":"Fritz","year":"2000","edition":"3rd"},{"key":"2026032004353029700_ref9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ygyno.2016.10.019","article-title":"The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)","volume":"144","author":"Matz","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2026032004353029700_ref10","volume-title":"SEER summary staging manual\u20142000: Codes and coding instructions","author":"Young","year":"2001"},{"key":"2026032004353029700_ref11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Pohar Perme","year":"2012","journal-title":"Biometrics"},{"key":"2026032004353029700_ref12","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9&lt;2004::AID-CNCR23&gt;3.0.CO;2-#","article-title":"An alternative approach to monitoring cancer patient survival","volume":"78","author":"Brenner","year":"1996","journal-title":"Cancer"},{"key":"2026032004353029700_ref13","article-title":"Life table by prefecture in","author":"Ministry of Health, Labour and Welfare","year":"2000"},{"key":"2026032004353029700_ref14","article-title":"Life table by prefecture in","author":"Ministry of Health, Labour and Welfare","year":"2005"},{"key":"2026032004353029700_ref15","article-title":"Life table by prefecture in","author":"Ministry of Health, Labour and Welfare","year":"2010"},{"key":"2026032004353029700_ref16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1186\/s12889-015-2534-3","article-title":"Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations","volume":"15","author":"Rachet","year":"2015","journal-title":"BMC Public Health"},{"key":"2026032004353029700_ref17","volume-title":"Life tables for the CONCORD programme","author":"Di Carlo","year":"2018"},{"key":"2026032004353029700_ref18","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardising survival ratios","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur J Cancer"},{"key":"2026032004353029700_ref19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/1536867X1401400107","article-title":"Net survival estimation with Stns","volume":"14","author":"Clerc-Urm\u00e8s","year":"2014","journal-title":"The Stata Journal"},{"key":"2026032004353029700_ref20","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S1470-2045(21)00403-4","article-title":"The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis","volume":"22","author":"Ward","year":"2021","journal-title":"Lancet Oncol"},{"key":"2026032004353029700_ref21","year":"2024"},{"key":"2026032004353029700_ref22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/jjco\/hyw008","article-title":"The Japanese guidelines for breast cancer screening","volume":"46","author":"Hamashima","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"2026032004353029700_ref23","author":"Foundation for Promotion of Cancer Research","year":"2016","journal-title":"Cancer Statistics in Japan 2015"},{"key":"2026032004353029700_ref24","article-title":"Prescription drug information search (in Japanese)","author":"Pharmaceuticals and Medical Devices Agency"},{"key":"2026032004353029700_ref25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(07)60028-2","article-title":"HERA study team 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial","volume":"369","author":"Smith","year":"2007","journal-title":"Lancet"},{"key":"2026032004353029700_ref26","doi-asserted-by":"crossref","first-page":"ii174","DOI":"10.1093\/annonc\/mdi704","article-title":"Neo-adjuvant therapy in breast cancer","volume":"16","author":"Bafaloukos","year":"2005","journal-title":"Ann Oncol"},{"key":"2026032004353029700_ref27","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Early breast cancer trialists' collaborative group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"2026032004353029700_ref28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"},{"key":"2026032004353029700_ref29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12282-022-01423-4","article-title":"Characteristics of female breast cancer in Japan: annual report of the National Clinical Database in 2018","volume":"30","author":"Tada","year":"2023","journal-title":"Breast Cancer"},{"key":"2026032004353029700_ref30","doi-asserted-by":"publisher","first-page":"19069","DOI":"10.1038\/s41598-024-69006-1","article-title":"Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021","volume":"14","author":"Barclay","year":"2024","journal-title":"Sci Rep"},{"key":"2026032004353029700_ref31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.breast.2016.10.005","article-title":"Improved survival in metastatic breast cancer 1985-2016","volume":"31","author":"Sundquist","year":"2017","journal-title":"Breast"},{"key":"2026032004353029700_ref32","doi-asserted-by":"publisher","first-page":"13774","DOI":"10.1002\/cam4.6016","article-title":"Fifteen-year survival and conditional survival of women with breast cancer in Osaka, Japan: a population-based study","volume":"12","author":"Kato","year":"2023","journal-title":"Cancer Med"},{"key":"2026032004353029700_ref33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ijc.2910540408","article-title":"Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991","volume":"54","author":"Sigurdsson","year":"1993","journal-title":"Int J Cancer"},{"key":"2026032004353029700_ref34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"2026032004353029700_ref35","article-title":"IARC handbooks of cancer prevention","author":"IARC Working Group on Evaluation of Cancer-Preventive Interventions. Cervical Cancer Screening. Lyon (FR): International Agency for Research on Cancer"},{"key":"2026032004353029700_ref36","author":"Ministry of Health, Labour and Welfare","year":"2008"},{"key":"2026032004353029700_ref37","article-title":"Guidelines for implementing priority health education and cancer screening for cancer prevention (in Japanese)","author":"Ministry of Health, Labour and Welfare","year":"2024"},{"key":"2026032004353029700_ref38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"key":"2026032004353029700_ref39","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","author":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026032004353029700_ref40","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1200\/JCO.2004.04.170","article-title":"Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study","volume":"22","author":"Moore","year":"2004","journal-title":"J Clin Oncol"},{"key":"2026032004353029700_ref41","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1158\/0008-5472.CAN-18-3109","article-title":"Epidemiologic and clinical analysis of cervical cancer using data from the population-based Osaka cancer Registry","volume":"79","author":"Yagi","year":"2019","journal-title":"Cancer Res"},{"key":"2026032004353029700_ref42","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in Gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"2026032004353029700_ref43","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"2026032004353029700_ref44","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1200\/JCO.2000.18.17.3084","article-title":"Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer","volume":"18","author":"Neijt","year":"2000","journal-title":"J Clin Oncol"},{"key":"2026032004353029700_ref45","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1470-2045(22)00283-2","article-title":"Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial","volume":"23","author":"Clamp","year":"2022","journal-title":"Lancet Oncol"},{"key":"2026032004353029700_ref46","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S1470-2045(13)70363-2","article-title":"Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial","volume":"14","author":"Katsumata","year":"2013","journal-title":"Lancet Oncol"},{"key":"2026032004353029700_ref47","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S1470-2045(15)00086-8","article-title":"Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial","volume":"16","author":"Oza","year":"2015","journal-title":"Lancet Oncol"},{"key":"2026032004353029700_ref48","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N Engl J Med"},{"key":"2026032004353029700_ref49","doi-asserted-by":"publisher","first-page":"x27","DOI":"10.1093\/annonc\/mdt465","article-title":"State of the art of surgery in advanced epithelial ovarian cancer","volume":"24","author":"Hacker","year":"2013","journal-title":"Ann Oncol"},{"key":"2026032004353029700_ref50","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ygyno.2016.11.019","article-title":"Worldwide comparison of ovarian cancer survival: histological group and stage at diagnosis (CONCORD-2)","volume":"144","author":"Matz","year":"2017","journal-title":"Gynecol Oncol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/Supplement_1\/i73\/67423478\/hyaf114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/Supplement_1\/i73\/67423478\/hyaf114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:35:42Z","timestamp":1773995742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/Supplement_1\/i73\/8529757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,3,20]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaf114","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]}}}